UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030480
Receipt number R000034803
Scientific Title Bed Sensor vital-sign monitoring System with under-the-bed load cells-A trial for clinical use
Date of disclosure of the study information 2017/12/22
Last modified on 2023/10/17 11:18:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Bed Sensor vital-sign monitoring System with under-the-bed load cells-A trial for clinical use

Acronym

A clinical use of Bed Sensor System

Scientific Title

Bed Sensor vital-sign monitoring System with under-the-bed load cells-A trial for clinical use

Scientific Title:Acronym

A clinical use of Bed Sensor System

Region

Japan


Condition

Condition

Inpatients in Palliative Care Unit

Classification by specialty

Not applicable Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We have developed an integrated non-invasive contact-free vital-signs monitor with four load cells under the bed. This project aims to provide a system to allow all medical staff to utilize this bed sensor vital sign monitoring system.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Early detection of patient abnormality

Key secondary outcomes

Reduction of medical staff burden


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

In-patients in Palliative Care Unit

Key exclusion criteria

None

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Shiroh
Middle name
Last name Isono

Organization

Chiba University

Division name

Graduate School of Medicine, Anesthesiology

Zip code

260-8670

Address

1-8-1 Inohana Chuo Chiba

TEL

043-226-2155

Email

shirohisono@yahoo.co.jp


Public contact

Name of contact person

1st name Natsuko
Middle name
Last name Taguchi

Organization

Chiba University

Division name

Graduate School of Medicine, Anesthesiology

Zip code

260-8670

Address

1-8-1 Inohana Chuo Chiba

TEL

043-226-2155

Homepage URL


Email

nnoztag@faculty.chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Other

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

MinebeaMitsumi Ltd

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University School of Medicine

Address

1-8-1 Inohan Chuo Chiba

Tel

043-222-7171

Email

igaku-rinri@office.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 22 Day


Related information

URL releasing protocol

https://journals.physiology.org/doi/full/10.1152/japplphysiol.00904.2020?rfr_dat=cr_pub++0pubmed&url

Publication of results

Published


Result

URL related to results and publications

https://journals.physiology.org/doi/full/10.1152/japplphysiol.00904.2020?rfr_dat=cr_pub++0pubmed&url

Number of participants that the trial has enrolled

120

Results

Respiratory rate was lower and breathing irregularity was higher in patients treated with opioids, throughout the day. We conclude that respiratory rhythm irregularities are the main feature of opioid dose-dependent respiratory depression, especially in female patients with advanced cancer.

Results date posted

2023 Year 10 Month 17 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 06 Month 13 Day

Baseline Characteristics

Patients with advanced cancer hospitalized for palliative care (on opioid n=39, with no opioid n=12)

Participant flow

Patients were explained of the purpose and methods of the research and gave written informed consent

Adverse events

None

Outcome measures

Respiratory instability

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 22 Day

Date of IRB

2016 Year 11 Month 22 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry

2021 Year 09 Month 30 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Direct questionnaire to the medical staff after the
development of the software.


Management information

Registered date

2017 Year 12 Month 20 Day

Last modified on

2023 Year 10 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034803


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name